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Abstract With the exception of two cases, keratin is not 
expressed in cultured human melanoma cells. Using 2D-PAGE, 
immunological and electron microscopic analyses, we found 
keratin subunits in five established cultured cell lines derived 
from primary, recurrent and metastasized melanomas. The 
keratin subunits were composed of Kl, K5, K10, K14, K15 and 
K18 in all cell lines examined, together with vimentin. In 
addition, K8, K16 and K18 expression were demonstrated in 
recurrent and metastasized cell lines. The results of the present 
and our previous study [Katagata Y, et al. J Dermatol Sei 
1996;13:219-227] indicate that expression of keratin in mela-
noma cells may be a universal phenomenon. A specific increase in 
the proportion of K5 among the keratin subunits was suggestive 
of the nature of melanoma cells. Moreover, we detected two 
polypeptides that migrated on 2D-PAGE at positions which did 
not correspond to those of any keratin subunit. The amino acid 
sequences of these two polypeptides were determined; one was 
the human ATP synthase cc-chain but the other did not match 
any known polypeptide in our homology search. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Keratin is a component of intermediate filaments, and the 
major structural protein of epithelial cells, including keratino-
cytes, showing the greatest heterogeneity of all intermediate 
filament proteins [1,2]. Keratin subunits have roles in the 
structure and formation of epithelial cells [3,4] and also in 
the reorganization of cells during mitosis [5-7]. On the other 
hand, human melanocytes are developmentally derived from 
neural crest cells and are localized in the basal cell layer of the 
epidermis [8]. The main functions of melanocytes are to pro-
duce melanin and to supply the melanin to the epidermis as a 
means of protection against ultraviolet irradiation. 
Proliferation is the major characteristic of malignancy in 
many tissues [9]. It was reported previously that among the 
intermediate filaments only vimentin was expressed in six hu-
man and two murine melanoma cell lines, and co-expression 
of vimentin and keratin(s) was found only in the human mel-
anoma cell line M5 [10]. The keratin subunits in these cells 
consisted of the so-called simple epithelial keratins (K7, K8, 
K17 and K18) and non-keratinized keratm (K13). Subse-
quently, a correlation was also reported between the co-ex-
pression of vimentin with simple epithelial K8 and K18 and 
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Abbreviations : 2D-PAGE, two-dimensional polyacrylamide gel elec-
trophoresis; K, keratin; SCC, squamous cell carcinoma 
the invasive and metastatic behavior of three human melano-
ma cell lines [11]. A high salt solution was employed to pre-
pare keratin subunits in the above two studies, and we dem-
onstrated that such a solution is not suitable for analysis of 
keratin subunits in cultured melanoma [12] or SCC cell lines 
[13-15]. 
In this report, we describe keratin subunits expressed in 
cultured melanoma cell lines derived from primary, recurrent, 
and metastasized melanomas. All of the cell lines employed in 
this study expressed a novel polypeptide that did not corre-
spond to any keratin in terms of molecular weight (Afr) or 
isoelectric point (p7) and that was not present in the BLAST 
homology database. This polypeptide may play an important 
role in the development of melanoma cells. 
2. Materials and methods 
2.1. Cell lines and culture methods 
Primary melanoma (PM)-WK, recurrent primary melanoma 
(RPM)-MC, and RPM-EP cell lines were established from three mel-
anomas (one original and two recurrent). Malignant melanoma 
(MM)-LH and MM-RU cell lines were also established from melano-
mas that had metastasized to the lung and lymph nodes, respectively 
[16]. Each cell line was named using the patient's initials. These five 
cultured melanoma cell lines were gifts from Dr. R.H. Byers (Depart-
ment of Pathology, Boston University School of Medicine, Boston, 
MA, USA). We maintained the cells in culture for no longer than 10 
days during each set of experiments to ensure that their metastatic 
phenotype would not change as a result of prolonged passage in vitro. 
Continuous cell cultures were routinely grown as monolayers in plas-
tic dishes (78.5 cm2, Falcon Plastics, Becton Dickinson Labware, 
Franklin Lakes, NJ, USA) at 37°C in a humidified incubator with 
5°/] C02 in air. We serially cultured all cell lines at plating densities of 
approximately 1.5 X 103 cells/cm2 in Minimum Essential Medium sup-
plemented with 10% fetal calf serum (Gibco Laboratories, Grand 
Island, NY, USA), penicillin (100 units/ml), streptomycin (50 ug/ 
ml), kanamycin (50 ug/ml), and hydrocortisone (0.4 ug/ml). Cell num-
bers were determined using a hemocytometer. Normal human mela-
nocytes were also cultured using human foreskin melanocyte cell kits 
(Morinaga Institute of Biological Science, Yokohama, Japan). 
2.2. Extraction of keratin polypeptides 
After several days, when the cultured cells had reached approxi-
mately 80% confluence, cells were quickly rinsed twice with calcium-
and magnesium-free phosphate-buffered saline (CMF-PBS) and 
scraped off with a rubber policeman in 1 ml of the aqueous solution 
(10 mM Tris-HCl (pH 7.4)/10 mM EDTA/phenylmethylsulfonyl fluo-
ride (PMSF, 10 ug/ml)). The cells were sonicated for 15 s using an 
ultrasonic disrupter (Tomy, UR-20p, Tokyo, Japan) at a power out-
put setting of 7, and centrifuged at 10000 rpm for 10 min. The residue 
was then washed by centrifugation (lOOOOXg, 10 min) 3 times to 
remove aqueous soluble materials. The residue was dissolved in 50 
ul of 10 M urea/10% 2-mercaptoethanol at 37°C for 6 h [17]. After 
centrifugation, one-tenth of the supernatant was treated with the same 
volume of 2XSDS buffer [18] for 3 min at 100°C, then the treated 
solution was subjected to SDS-PAGE (10% polyacrylamide) gels. To 
minimize contamination, all experimental procedures were carried out 
using sterile apparatus and conditions. 
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2.3. SDS-PAGE keratins were carried out with an ATTO Densitograph AE6920-M 
SDS-PAGE was carried out by the standard method [18]. Analysis using photographs of gels stained with Coomassie brilliant blue 
of keratin polypeptides by 2D-PAGE was performed as described [19] (CBB) R-250. 
with ampholytes of pH 3.5-10 (LKB, Bromma, Sweden) using the 
remaining 45 ill of each fraction. Quantitative analyses of expressed 
Fig. 1. 2D-PAGE of keratin subumts extracted from five cultured human melanoma and normal melanocyte cells. A: PM-WK; B: RPM-MC; 
C: RPM-EP; D: MM-LH; E: MM-RU; F : normal melanocyte cells. Standard proteins: P, 3'-phosphoglycerokinase (pi 7.4, MT 43 kDa); 
B, bovine serum albumin (pi 6.35, Mr 68 kDa); A, rabbit a-actin (pi 5.4, MT 42 kDa). The numbers denoted keratin nomenclature according 
to Moll et al. [2]. Separation of the proteins in the first dimension was by nonequilibrium pH gradient gel electrophoresis (NEpGE) and in the 
second dimension by 12.5% polyacrylamide gels containing sodium dodecyl sulfate (SDS). 
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2.4. Immunoblotting analyses 
After SDS-PAGE, proteins on the unstained gels were electroblot-
ted onto polyvinylidene difluoride (PVDF) membranes (0.2 mm, Bio-
Rad Lab., Hercules, CA, USA) at 2 mA/cm2 for 1 h using the stand-
ard procedure [20]. To block nonspecific protein binding sites on the 
PVDF membranes, they were incubated with defatted milk for 1 h. 
Membrane strips were washed in CMF-PBS containing 0.005% Tween 
20 and reacted with anti-keratin monoclonal antibodies (34ßB4, Enzo 
Diagnostic, New York, NY, USA; 34ßE12 and 35ßHll, DAKO A/S, 
Glostrup, Denmark; LL002, Cymbus Bioscience Ltd., Southampton, 
UK; V9 (anti-vimentin), Boehringer Mannheim Biochemica, Mann-
heim, Germany) at a dilution of 1:50 in CMF-PBS at 37°C for 40 
min. The strips were washed in CMF-PBS containing 0.005% Tween 
20 and incubated with peroxidase-conjugated anti-mouse immunoglo-
bulin rabbit serum (Dako Corp.) 1:300 at 37°C for 40 min. After 
washing with CMF-PBS containing 0.005% Tween 20, the strips 
were reacted in 0.03% 3,3'-diaminobenzidine/0.01% hydrogen perox-
ide/Tris-HCl buffer (pH 7.6) and washed in distilled water. Staining of 
standard proteins on the PVDF membranes was performed with 
0.04% CBB R-250. 
2.5. Electron microscopy 
Cultured melanoma cells were prepared for electron microscopy by 
addition of 1 ml of 2.5% glutaraldehyde in 2 mM cacodylate buffer at 
pH 7.4 for 30 min and 1 ml of 2 mM osmium tetroxide to each dish at 
4°C for 2 h. Then, the dishes were dehydrated by passage through a 
graded ethanol series and embedded in Quetol 812. Ultrathin sections 
were stained with uranyl acetate and lead citrate and examined under 
an electron microscope. 
2.6. Amino acid sequence 
After 2D-PAGE, the gels were electroblotted onto PVDF mem-
branes with a semidry apparatus (ATTO Co. Ltd., Tokyo, Japan) 
at 2 mA/cm2 for 40 min. The blotted membranes were then stained 
with CBB R-250. Two spots that were not keratin polypeptides were 
cut out and their amino acid sequences determined using an auto-
mated protein sequencer (Applied Biosystems 470A, Perkin-Elmer 
Co., Rockville, MD, USA). When the N-terminal amino acid of the 
polypeptide was blocked, the sequence was determined with a protein 
1Amino acid sequences are shown by one letter indication. 
2Melanoma related protein-1 (asterisks in Fig. 1A-E). —, not detected. 
3The sequence of ATP synthase a-chain [21]. 
Arrows in Fig. 1A-F. 
N-terminal deblocking kit, according to the manufacturer's protocol 
(Takara Biomedicals Co. Ltd., Kyoto, Japan). 
3. Results 
3.1. SDS- and2D-PAGE 
Keratin subunits were prepared from cultured melanoma 
cell lines using an aqueous rather than a high salt solution 
which many researchers have employed in previous studies. 
The extracts were subjected to SDS-PAGE, and the resultant 
profiles indicated the presence of more than six keratin sub-
units with Mr values between 40 and 67 kDa [2] in five mel-
anoma cell lines (data not shown). 
To identify the keratin subunits extracted from each cell 
line, we performed 2D-PAGE. The results confirmed the pres-
ence of seven keratin subunits (Kl, K5, K10, K14, K15, K16, 
and K18) in all cell lines examined and K8 was expressed in 
all but two cell lines (PM-WK and RPM-EP) (Fig. 1 and 
Table 1). Moreover, we detected two unknown spots (MT 
ca. 80 kDa, pi 7.8; MT ca. 48 kDa, pi 8.2) at the same posi-
tions in each cell line (labeled with asterisk and arrow, respec-
tively, Fig. 1A-E). In normal melanocytes, only the former 
spot was detected (Fig. IF). Vimentin expression was also 
confirmed with V9 anti-vimentin monoclonal antibody (data 
not shown). 
3.2. Amino acid sequences 
The amino acid sequences of the two unknown spots were 
determined with an automated amino acid sequencer using the 
extract from each membrane. The smaller spot (marked with 
an arrow; MY ca. 48 kDa, pi 8.2) corresponded very closely 
(85.7%) with the just mature N-terminal region of ATP syn-
thase a-chain [21]. The N-terminus of the larger spot (marked 
with an asterisk) was blocked; however, its amino acid se-
quence was elucidated (Table 2). From the results of a 
BLAST homology search, this sequence did not correspond 
to any known protein, and we have tentatively named it mel-
anoma-related protein (MRP)-l. 
3.3. Quantitative analyses of keratin subunits, ATP synthase 
a-chain and MRP-1 
To elucidate the relative amounts of each keratin subunit, 
ATP synthase a-chain and MRP-1, we analyzed gels stained 
Table 2 
The amino acid sequences determined of MRP-1 and ATP synthase a-chain1 
MRP-12' 1 5 10 20 30 
(Mr, Ca. 80 Kd, pi 7.8) EGVVVR VLSGILDDGG RNLIYKLSID 
Arrow marks; Q K T G T A E M S F I L E E V I L G N D T 
(Mr, Ca. 48 Kd, pi 8.2) 
ATP synthase a-subunits3); N L H A S N T R L Q K T G T A E M S S I L E E R I L G N D T S V D L E 
35 40 44 50 60 65 
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with CBB R-250 using the Densitograph 3.1 program on a 
Macintosh computer. The densitographic results of each cell 
line are illustrated, showing relative amounts of each compo-
nent (Fig. 2). Levels of K5 subunit were high in recurrent and 
metastasized melanoma cell lines, and MRP-1 and/or ATP 
synthase cc-chain were also abundant in these cells. 
3.4. Immunoblotting analyses 
After SDS-PAGE, the electroblotted strips were reacted 
with several anti-keratin and anti-vimentin monoclonal anti-
bodies. Only 34ßB4 was also reacted to several bands, except 
for Kl (Fig. 3). 
3.5. Electron microscopy 
Electron micrographs of each cultured melanoma cell line 
showed large and dense bundles of tonofilaments in the cyto-
plasm. The tonofilaments were located close to the plasma 
membrane rather than in the perinuclear space (Fig. 4), in 
contrast to the results reported previously in human melano-
cytes [22]. 
4. Discussion 
In this study, we employed an aqueous solution as a buffer 
to prepare keratin subunits from melanoma cell lines. 
Although highly concentrated salt and detergent (KC1, NaCl 
and Triton X-100) have been employed by many researchers 
to prepare keratin subunits from malignant neoplasms [23,24], 
cultured SCC [25,26] and melanoma cell lines [10,11], these 
reagents were originally used on native tissues or tumors to 
remove large amounts of subcutaneous fat tissues [27,28]. In 
fact, we demonstrated previously that this aqueous solution 
was more efficient than the high salt solution (1.5 M KCl/1% 
Triton X-100/150 mM NaCl/10 mM Tris-HCl (pH 7.4)/5 mM 
EDTA/PMSF (10 ug/ml)) [27] for detection of keratin sub-
units in cultured SCC [13-15] and melanoma cell lines [12]. 
Thus, we considered that high salt solution may be too harsh 
for cultured cells. 
Torejdosiewicz et al. [10] reported that five keratin subunits 
(simple epithelial and non-keratinized types) were expressed 
together with vimentin in only the M5 human melanoma 
cell line, and no keratin was detected in five other human 
and two mouse melanoma cell lines. Since we estimated 
more than six kinds of keratin subunits in cultured melanoma 
cell lines by SDS-PAGE (data not shown), we performed 20 -
PAGE to characterize them further because 2D-PAGE sys-
tems are superior for differentiation between the 21 kinds of 
keratin subunits with similar Mr (40-67 kDa) and p / (4.9-
7.8). As shown in Fig. 1A-F, we confirmed the presence of 
stratified, hyperproliferative and other types of keratins, to-
gether with vimentin, as determined by the values of MT and 
pi in all melanoma cell lines examined (Table 1). Small 
amounts of K8, a marker of late stage metastasis, and K18 
[29,30] were present in specific melanoma cell lines, especially 
RPM-MC, MMs-LH and -RU. Combined with K13, which is 
a marker of early stage metastasis [31,32], these subunits are 
Fig. 2. The relative percentages of keratin subunits, MRP-1, and 
ATP synthase cx-chain expressed in five melanoma cell lines and 
normal melanocyte cells. In each panel, bars from left to right indi-
cate Kl , K5, K10, K14, K15, K8, K18, MRP-1, and ATP synthase 
a-chain, respectively. 
Fig. 3. Immunoblot analyses of keratin subunits extracted from five 
melanoma cells with keratin monoclonal antibodies: 34ßB4 (against 
Kl), 34ßE12 (against Kl , K5, K10 and K14), 35ßH12 (against K8), 
LL002 (against K14), V9 (against vimentin). Standard proteins 
which stained with 0.04% CBB R-250 after transfer: 92.5, phosphor-
ylase A; 68, bovine serum albumin; 45, ovalbumin (kDaX 103). 
known to be related to tumor invasion and to changes in 
epithelial-mesenchymal interactions [33]. In addition to the 
above reports, Hendrix et al. [11] demonstrated that co-ex-
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Fig. 4. Electron micrographs of the filaments in five melanoma cells. The filaments (arrow) are shown near the plasma membrane rather than 
perinuclear. A: PM-WK; B: RPM-MC; C: RPM-EP; D: MM-LH; E: MM-RU (X3000); F: MM-RU (X20000). A-D, F: magnification 
X20000. Scale bar, 1 um. E: magnification X3000. Scale bar, 1 um. F: high magnification (X20000) of the circled region in E. M, mitochon-
dria; N, nucleus. 
pression of vimentin with K8 and K18 subunits was highly 
correlated with the invasive and metastatic behavior of human 
melanoma cells. Our results were in accordance with those of 
the above reports, indicating the presence of keratin subunits 
in all the cell lines examined. Furthermore, the expression of 
ATP synthase oc-chain may be common in cultured cells, be-
cause this polypeptide was reported to be expressed in six 
cultured SCC lines [13-15], eight melanoma cell lines [12], 
and cultured melanocytes (Fig. IF), and was detected in five 
of the melanoma cell lines examined in this study. It seems 
reasonable to suppose that this component plays fundamental 
roles in cultured cells. The observation that MRP-1 was ex-
pressed in only five of the melanoma cell lines employed in 
this study, and was not expressed in normal melanocytes, 
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suggests a unique role of this molecule in cell behavior and 
function. All these findings were possible because we em-
ployed an aqueous instead of a high salt solution as a buffer 
for cultured melanoma cell lines. Many investigators may 
therefore have overlooked ATP synthase a-chain and MRP-
1 due to the use of high salt solution. 
The relative amounts of keratin subunits in PM-WK, which 
expressed MRP-1 and ATP synthase a-chain, were not sig-
nificantly different. As this cell line was established and de-
rived from a nodular melanoma, the relative amounts of ker-
atin subunits may be similar to those of human melanoma 
cells in vivo. On the other hand, the keratin contents in re-
current (RPMs-MC and -EP) and metastatic (MMs-LH and 
-RU) cell lines were not constant and showed a characteristic 
value for each cell line. However, there was a tendency in 
these cell lines for higher levels of type II (Kl and K5 in 
this case) than type I (K10 and K14 in this case). As K5 
and K14 are expressed only in the basal cells, this relationship 
may be reflected in the above phenomena. This may also be 
related to the observation that type II keratin gene induces 
type I keratin expression [34]. From the results presented 
above, we believe that the expression of MRP-1 and/or ATP 
synthase a-chain may also be necessary to act at the first step 
of recurrence or metastasis of melanoma cells. 
To confirm the presence of keratin subunits in the melano-
ma cell lines, we performed immunological analyses using 
several anti-keratin monoclonal antibodies (Fig. 3). With the 
exception of 34ßB4, the results indicated the co-expression of 
vimentin and keratin in all melanoma cell lines employed, 
similarly to many other cultured and tumor cells [11,35,36]. 
The co-expression of these molecules may be essential for 
maintenance of the epithelial cells themselves. Morphological 
analyses should be performed to elucidate cell structure and 
function. With the exception of one report [22] of 10 nm 
filaments in human melanocytes, there is no evidence that 
keratin filaments are present in melanoma cells. In the above 
study, the filaments shifted from the perinuclear area to the 
center of the dendritic processes in close association with mel-
anosomes during different stages of UV-mediated melanin 
pigmentation. The discrepancy between our findings and 
theirs may be due to the melanoma cells employed. Keratin 
expression may be related to changes from melanocytes to 
melanoma cells, together with the expression of MRP-1, 
which is absent in melanocytes (Figs. 1 and 2). 
In conclusion, the results of this study (Figs. 1^1) combined 
with those in our previous report [12] suggest that keratin 
subunits are universally present in cultured melanoma cells. 
In addition, our results indicated that ATP synthase a-chain 
and/or MRP-1 together with keratin subunits and vimentin 
may play significant roles in melanoma cell structure, meta-
stasis, and recurrence. 
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